Literature DB >> 16520523

Diabetes and depression care among medicaid beneficiaries.

Usha Sambamoorthi1, Mark Olfson, Wenhui Wei, Stephen Crystal.   

Abstract

This study evaluates the relationship between diabetes mellitus and depression care among non-elderly Medicaid beneficiaries, using claims data from the 1995 State Medicaid Research Files for Alabama, Georgia, New Jersey, and Wisconsin. Presence of comorbid diabetes was found to be significantly associated with a higher rate of depression diagnosis. Among those who were diagnosed as depressed, treatment of comorbid diabetes was associated with a higher rate of antidepressant treatment than among depression-diagnosed patients who did not also have diabetes. However, among patients with diabetes and depression, a quarter received only tricyclic antidepressants. Controlling for other characteristics, African Americans diagnosed with depression were less likely to receive antidepressant treatment and, if they did receive such treatment, more likely to receive the older tricyclic drugs. These findings raise concern for glycemic control among patients with diabetes and depression treated with tricyclic antidepressants in a low-income Medicaid population. Among depressed Medicaid beneficiaries with diabetes, there are racial differences with regard to quality of mental health care in the presence of diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16520523     DOI: 10.1353/hpu.2006.0034

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  8 in total

1.  Comorbid chronic illness and the diagnosis and treatment of depression in safety net primary care settings.

Authors:  Chizobam Ani; Mohsen Bazargan; David Hindman; Douglas Bell; Michael Rodriguez; Richard S Baker
Journal:  J Am Board Fam Med       Date:  2009 Mar-Apr       Impact factor: 2.657

2.  Crowd-out and exposure effects of physical comorbidities on mental health care use: implications for racial-ethnic disparities in access.

Authors:  Benjamin Lê Cook; Thomas G McGuire; Margarita Alegría; Sharon-Lise Normand
Journal:  Health Serv Res       Date:  2011-03-17       Impact factor: 3.402

3.  Quality of depression treatment in Black Americans with major depression and comorbid medical illness.

Authors:  Amma A Agyemang; Briana Mezuk; Paul Perrin; Bruce Rybarczyk
Journal:  Gen Hosp Psychiatry       Date:  2014-03-07       Impact factor: 3.238

4.  Relationship Between General Illness and Mental Health Service Use and Expenditures Among Racially-Ethnically Diverse Adults ≥65 Years.

Authors:  Daniel E Jimenez; Benjamin Lê Cook; Giyeon Kim; Charles F Reynolds; Margarita Alegría; Sarah Coe-Odess; Stephen J Bartels
Journal:  Psychiatr Serv       Date:  2015-03-16       Impact factor: 3.084

5.  Racial disparities in the treatment of depression in low-income persons with diabetes.

Authors:  Chandra Y Osborn; Hollister W Trott; Maciej S Buchowski; Kushal A Patel; Leslie D Kirby; Margaret K Hargreaves; William J Blot; Sarah S Cohen; David G Schlundt
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

6.  Retrospective analysis of diabetes care in California Medicaid patients with mental illness.

Authors:  Jim E Banta; Elaine H Morrato; Scott W Lee; Mark G Haviland
Journal:  J Gen Intern Med       Date:  2009-05-05       Impact factor: 5.128

7.  Depression in diabetic patients attending University of Gondar Hospital Diabetic Clinic, Northwest Ethiopia.

Authors:  Anteneh Messele Birhanu; Fekadu Mazengia Alemu; Tesfaye Demeke Ashenafie; Shitaye Alemu Balcha; Berihun Assefa Dachew
Journal:  Diabetes Metab Syndr Obes       Date:  2016-05-11       Impact factor: 3.168

8.  Depression treatment decreases healthcare expenditures among working age patients with comorbid conditions and type 2 diabetes mellitus along with newly-diagnosed depression.

Authors:  Rituparna Bhattacharya; Chan Shen; Amy B Wachholtz; Nilanjana Dwibedi; Usha Sambamoorthi
Journal:  BMC Psychiatry       Date:  2016-07-19       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.